Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 8, keine Gesamtzahl für „moderate“
Suchtreffer
Begriffe & Kennungen
Docetaxel Kabi · 4.8 · Reversible cutaneous reactions have been observed and were generally considered as mild to moderate. Reactions
Eintrag öffnenDoptelet · 4.5 · Concomitant use of avatrombopag with moderate or strong CYP3A4/5 and CYP2C9 dual inhibitors (e.g., fluconazole
Eintrag öffnenDoptelet · 4.5 · Concomitant use of moderate or strong CYP3A4/5 and CYP2C9 dual inducers (e.g., rifampicin, enzalutamide) reduc
Eintrag öffnenDoptelet · 4.5 · Increase the recommended starting dose of Doptelet when used concomitantly with a moderate or strong dual indu
Eintrag öffnenDoptelet · 4.5 · Reduce the starting dose of avatrombopag when used concomitantly with a moderate or strong dual inhibitor of C
Eintrag öffnenDuaklir Genuair · 4.8 · The Duaklir Genuair clinical development programme was conducted in patients with moderate or severe COPD. A t
Eintrag öffnenDuloxetine Lilly · 4.5 · Medicinal products metabolised by CYP2D6: Duloxetine is a moderate inhibitor of CYP2D6. When duloxetine was ad
Eintrag öffnenDuloxetine Lilly · 4.8 · Generally, for SSRIs and SNRIs, these events are mild to moderate and self-limiting, however, in some patients
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.5 · Medicinal products metabolised by CYP2D6 Duloxetine is a moderate inhibitor of CYP2D6. When duloxetine was adm
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.8 · Generally, for SSRIs and SNRIs, these events are mild to moderate and self-limiting, however, in some patients
Eintrag öffnenDuloxetine Zentiva · 4.5 · Medicinal products metabolised by CYP2D6 Duloxetine is a moderate inhibitor of CYP2D6. When duloxetine was adm
Eintrag öffnenDuloxetine Zentiva · 4.8 · Generally, for SSRIs and SNRIs, these events are mild to moderate and self-limiting, however, in some patients
Eintrag öffnenDupixent · 4.8 · Children 6 to 11 years of age In children 6 to 11 years of age with moderate-to-severe asthma (VOYAGE), the ad
Eintrag öffnenDupixent · 4.8 · Children 6 to 11 years of age In children 6 to 11 years of age with moderate-to-severe asthma (VOYAGE), the ad
Eintrag öffnenDupixent · 4.8 · In children 6 to 11 years of age with moderate-to-severe asthma, eosinophilia (blood eosinophils ≥ 3,000 cells
Eintrag öffnenDupixent · 4.8 · In children 6 to 11 years of age with moderate-to-severe asthma, eosinophilia (blood eosinophils ≥ 3,000 cells
Eintrag öffnenEbglyss · 4.8 · The safety of lebrikizumab was assessed in 372 patients 12 to 17 years of age with moderate-to-severe atopic d
Eintrag öffnenEdurant · 4.8 · All ADRs were mild or moderate. ADRs reported in at least 2 participants, regardless of severity, were: decrea
Eintrag öffnenEdurant · 4.8 · All ADRs were mild or moderate. ADRs reported in at least 2 participants, regardless of severity, were: decrea
Eintrag öffnenEdurant · 4.8 · All ADRs were mild or moderate. ADRs reported in at least 2 participants, regardless of severity, were: vomiti
Eintrag öffnen